{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:01:40Z","timestamp":1784286100170,"version":"3.55.0"},"reference-count":33,"publisher":"Keio Journal of Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Keio J. Med.","Keio j. med"],"published-print":{"date-parts":[[2025]]},"DOI":"10.2302\/kjm.2023-0010-ir","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T22:15:49Z","timestamp":1691619349000},"page":"21-26","source":"Crossref","is-referenced-by-count":3,"title":["Gorlin Syndrome and Cowden Syndrome"],"prefix":"10.2302","volume":"74","author":[{"given":"Hiroyuki","family":"Goto","sequence":"first","affiliation":[{"name":"Department of Dermatology, Osaka Metropolitan University Graduate School of              Medicine, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiharu","family":"Tateishi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Osaka Metropolitan University Graduate School of              Medicine, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Tsuruta","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Osaka Metropolitan University Graduate School of              Medicine, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1082","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gorlin RJ, Goltz RW: Multiple nevoid basal-cell          epithelioma, jaw cysts and bifid rib. A syndrome. N Engl J Med 1960; 262: 908\u2013912.          PMID:13851319 https:\/\/doi.org\/10.1056\/NEJM196005052621803","DOI":"10.1056\/NEJM196005052621803"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Onodera S, Nakamura Y, Azuma T: Gorlin syndrome:          recent advances in genetic testing and molecular and cellular biological research. Int J          Mol Sci 2020; 21: 7559. PMID:33066274          https:\/\/doi.org\/10.3390\/ijms21207559","DOI":"10.3390\/ijms21207559"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Narang A, Maheshwari C, Aggarwal V, Bansal P,          Singh P: Gorlin-Goltz syndrome with intracranial meningioma: case report and review of          literature. World Neurosurg 2020; 133: 324\u2013330. PMID:31605858          https:\/\/doi.org\/10.1016\/j.wneu.2019.09.156","DOI":"10.1016\/j.wneu.2019.09.156"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lin MJ, Dubin DP, Khorasani H, Giordano CN: Basal          cell nevus syndrome: from DNA to therapeutics. Clin Dermatol 2020; 38: 467\u2013476.          PMID:32972605 https:\/\/doi.org\/10.1016\/j.clindermatol.2020.03.003","DOI":"10.1016\/j.clindermatol.2020.03.003"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Verkouteren BJ, Sinx KA, Reinders MG, Aarts MJ,          Mosterd K: Update on hedgehog pathway inhibitor therapy for patients with basal cell          naevus syndrome or high-frequency basal cell carcinoma. Acta Derm Venereol 2022; 102: 980.          PMID:35535645 https:\/\/doi.org\/10.2340\/actadv.v102.980","DOI":"10.2340\/actadv.v102.980"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fujii K, Miyashita T: Gorlin syndrome (nevoid          basal cell carcinoma syndrome): update and literature review. Pediatr Int 2014; 56:          667\u2013674. PMID:25131638 https:\/\/doi.org\/10.1111\/ped.12461","DOI":"10.1111\/ped.12461"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kimonis VE, Goldstein AM, Pastakia B, Yang ML,          Kase R, DiGiovanna JJ, Bale AE, Bale SJ: Clinical manifestations in 105 persons with          nevoid basal cell carcinoma syndrome. Am J Med Genet 1997; 69: 299\u2013308. PMID:9096761          https:\/\/doi.org\/10.1002\/(SICI)1096-8628(19970331)69:3&lt;299::AID-AJMG16&gt;3.0.CO;2-M","DOI":"10.1002\/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.3.CO;2-#"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Betancourt NJ, Qian MF, Pickford JR, Bailey-Healy          I, Tang JY, Teng JM: Gorlin syndrome: assessing genotype-phenotype correlations and          analysis of early clinical characteristics as risk factors for disease severity. J Clin          Oncol 2022; 40: 2119\u20132127. PMID:35333541          https:\/\/doi.org\/10.1200\/JCO.21.02385","DOI":"10.1200\/JCO.21.02385"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Morita K, Naruto T, Tanimoto K, Yasukawa C,          Oikawa Y, Masuda K, Imoto I, Inazawa J, Omura K, Harada H: Simultaneous detection of both          single nucleotide variations and copy number alterations by next-generation sequencing in          Gorlin syndrome. PLoS One 2015; 10: e0140480. PMID:26544948          https:\/\/doi.org\/10.1371\/journal.pone.0140480","DOI":"10.1371\/journal.pone.0140480"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Spadari F, Pulicari F, Pellegrini M, Scribante A,          Garagiola U: Multidisciplinary approach to Gorlin-Goltz syndrome: from diagnosis to          surgical treatment of jawbones. Maxillofac Plast Reconstr Surg 2022; 44: 25. PMID:35843976          https:\/\/doi.org\/10.1186\/s40902-022-00355-5","DOI":"10.1186\/s40902-022-00355-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kiwilsza M, Sporniak-Tutak K: Gorlin-Goltz          syndrome\u2014a medical condition requiring a multidisciplinary approach. Med Sci Monit 2012;          18: RA145\u2013RA153. PMID:22936202 https:\/\/doi.org\/10.12659\/MSM.883341","DOI":"10.12659\/MSM.883341"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Axelson M, Liu K, Jiang X, He K, Wang J, Zhao H,          Kufrin D, Palmby T, Dong Z, Russell AM, Miksinski S, Keegan P, Pazdur R: U.S. Food and          Drug Administration approval: vismodegib for recurrent, locally advanced, or metastatic          basal cell carcinoma. Clin Cancer Res 2013; 19: 2289\u20132293. PMID:23515405          https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1956","DOI":"10.1158\/1078-0432.CCR-12-1956"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sekulic A, Migden MR, Basset-Seguin N, Garbe C,          Gesierich A, Lao CD, Miller C, Mortier L, Murrell DF, Hamid O, Quevedo JF, Hou J, McKenna          E, Dimier N, Williams S, Schadendorf D, Hauschild A, ERIVANCE BCC Investigators: Long-term          safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final          update of the pivotal ERIVANCE BCC study. BMC Cancer 2017; 17: 332. PMID:28511673          https:\/\/doi.org\/10.1186\/s12885-017-3286-5","DOI":"10.1186\/s12885-017-3286-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Burness CB: Sonidegib: first global approval.          Drugs 2015; 75: 1559\u20131566. PMID:26323341          https:\/\/doi.org\/10.1007\/s40265-015-0458-y","DOI":"10.1007\/s40265-015-0458-y"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kesireddy M, Mendiola VL, Jana B, Patel S:          Long-term response to vismodegib in a patient with Gorlin-Goltz syndrome: a case report          and review of pathological mechanisms involved. Cureus 2019; 11: e5383. PMID:31616614          https:\/\/doi.org\/10.7759\/cureus.5383","DOI":"10.7759\/cureus.5383"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hoashi T, Kanda N, Saeki H: Molecular mechanisms          and targeted therapies of advanced basal cell carcinoma. Int J Mol Sci 2022; 23: 11968.          PMID:36233269 https:\/\/doi.org\/10.3390\/ijms231911968","DOI":"10.3390\/ijms231911968"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Innella G, Miccoli S, Colussi D, Pradella LM,          Amato LB, Zuntini R, Salfi NC, Collina G, Ferrara F, Ricciardiello L, Turchetti D:          Colorectal polyposis as a clue to the diagnosis of Cowden syndrome: report of two cases          and literature review. Pathol Res Pract 2021; 218: 153339. PMID:33482532          https:\/\/doi.org\/10.1016\/j.prp.2020.153339","DOI":"10.1016\/j.prp.2020.153339"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. \u015eahin GE, Ho\u015fnut F\u00d6, Ye\u015fil \u015e, Lafc\u0131 NG, G\u00fcl AE,          \u015eahin G: Sirolimus treatment of a PTEN hamartoma tumor syndrome presenting with melena.          Turk J Pediatr 2022; 64: 766\u2013774. PMID:36082652          https:\/\/doi.org\/10.24953\/turkjped.2021.5330","DOI":"10.24953\/turkjped.2021.5330"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lloyd KM, 2nd, Dennis M: Cowden\u2019s disease. A          possible new symptom complex with multiple system involvement. Ann Intern Med 1963; 58:          136\u2013142. PMID:13931122 https:\/\/doi.org\/10.7326\/0003-4819-58-1-136","DOI":"10.7326\/0003-4819-58-1-136"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Miguelote S, Silva R, Fougo JL, Barbosa LE,          Ara\u00fajo Teixeira JP: Cowden syndrome is a risk factor for multiple neoplasm: a case report.          World J Surg Oncol 2020; 18: 211. PMID:32807196          https:\/\/doi.org\/10.1186\/s12957-020-01971-z","DOI":"10.1186\/s12957-020-01971-z"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Dragoo DD, Taher A, Wong VK, Elsaiey A, Consul N,          Mahmoud HS, Mujtaba B, Stanietzky N, Elsayes KM: PTEN hamartoma tumor syndrome\/Cowden          syndrome: genomics, oncogenesis, and imaging review for associated lesions and malignancy.          Cancers (Basel) 2021; 13: 3120. PMID:34206559          https:\/\/doi.org\/10.3390\/cancers13133120","DOI":"10.3390\/cancers13133120"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lim A, Ngeow J: The skin in Cowden syndrome.          Front Med (Lausanne) 2021; 8: 658842. PMID:34179044          https:\/\/doi.org\/10.3389\/fmed.2021.658842","DOI":"10.3389\/fmed.2021.658842"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Komiya T, Blumenthal GM, DeChowdhury R,          Fioravanti S, Ballas MS, Morris J, Hornyak TJ, Wank S, Hewitt SM, Morrow B, Memmott RM,          Rajan A, Dennis PA: A pilot study of sirolimus in subjects with Cowden syndrome or other          syndromes characterized by germline mutations in PTEN. Oncologist 2019; 24: 1510\u2013e1265.          PMID:31350329 https:\/\/doi.org\/10.1634\/theoncologist.2019-0514","DOI":"10.1634\/theoncologist.2019-0514"},{"key":"24","unstructured":"24. Yehia L, Eng C: PTEN hamartoma tumor syndrome.          In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, eds,          GeneReviews. Seattle (WA): University of Washington, 1993\u20132023."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Eng C: Will the real Cowden syndrome please stand          up: revised diagnostic criteria. J Med Genet 2000; 37: 828\u2013830. PMID:11073535          https:\/\/doi.org\/10.1136\/jmg.37.11.828","DOI":"10.1136\/jmg.37.11.828"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Sousa-Neto SS, de Arruda JA, Martins AF, Abreu          LG, Mesquita RA, Mendon\u00e7a EF: Orofacial manifestations assisting the diagnosis of Cowden          syndrome in a middle-aged patient: case report and literature overview. Head Neck Pathol          2021; 16: 304\u2013313. PMID:34106409          https:\/\/doi.org\/10.1007\/s12105-021-01345-1","DOI":"10.1007\/s12105-021-01345-1"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Arai H, Akagi K, Nakagawa A, Onai Y, Utsu Y,          Masuda S, Aotsuka N: Clinical and genetic diagnosis of Cowden syndrome: a case report of a          rare PTEN germline variant and diverse clinical presentation. Medicine (Baltimore) 2023;          102: e32572. PMID:36607858 https:\/\/doi.org\/10.1097\/MD.0000000000032572","DOI":"10.1097\/MD.0000000000032572"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Manning-Geist BL, Gatius S, Liu Y, Gil M, Da Cruz          Paula A, Tuset N, Abu-Rustum NR, Aghajanian C, Weigelt B, Matias-Guiu X: Diagnosis and          management of an endometrial cancer patient with Cowden syndrome. Gynecol Oncol 2021; 163:          14\u201321. PMID:34446268 https:\/\/doi.org\/10.1016\/j.ygyno.2021.08.008","DOI":"10.1016\/j.ygyno.2021.08.008"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hatta N, Horita Y: Undifferentiated pleomorphic          sarcoma in a patient with Cowden syndrome after radiotherapy for breast cancer. J Dermatol          2019; 46: e73\u2013e75. PMID:30047560 https:\/\/doi.org\/10.1111\/1346-8138.14584","DOI":"10.1111\/1346-8138.14584"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Fernandez C, Savard C, Farrell C, Shi W:          Successful stereotactic radiotherapy of meningiomas in a patient with Cowden syndrome: a          case report. Chin Clin Oncol 2020; 9: 38. PMID:32312055          https:\/\/doi.org\/10.21037\/cco.2020.03.04","DOI":"10.21037\/cco.2020.03.04"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Srivastava S, Jo B, Zhang B, Frazier T, Gallagher          AS, Peck F, Levin AR, Mondal S, Li Z, Filip-Dhima R, Geisel G, Dies KA, Diplock A, Eng C,          Hanna R, Sahin M, Hardan A, Sahin M, Eng C, Hardan A, Martinez-Agosto JA, Frazier T,          Developmental Synaptopathies Consortium: A randomized controlled trial of everolimus for          neurocognitive symptoms in PTEN hamartoma tumor syndrome. Hum Mol Genet 2022; 31:          3393\u20133404. PMID:35594551 https:\/\/doi.org\/10.1093\/hmg\/ddac111","DOI":"10.1093\/hmg\/ddac111"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez          N, Conde JG: Research electronic data capture (REDCap)\u2014a metadata-driven methodology and          workflow process for providing translational research informatics support. J Biomed Inform          2009; 42: 377\u2013381. PMID:18929686          https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Harris PA, Taylor R, Minor BL, Elliott V,          Fernandez M, O\u2019Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN, REDCap          Consortium: The REDCap consortium: building an international community of software          platform partners. J Biomed Inform 2019; 95: 103208. PMID:31078660          https:\/\/doi.org\/10.1016\/j.jbi.2019.103208","DOI":"10.1016\/j.jbi.2019.103208"}],"container-title":["The Keio Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/74\/1\/74_2023-0010-IR\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T04:05:06Z","timestamp":1743221106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/74\/1\/74_2023-0010-IR\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2302\/kjm.2023-0010-ir","relation":{},"ISSN":["0022-9717","1880-1293"],"issn-type":[{"value":"0022-9717","type":"print"},{"value":"1880-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2023-0010-IR"}}